Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Maria Rita Emma"'
Autor:
Stephen L. Abrams, Przemysław Duda, Shaw M. Akula, Linda S. Steelman, Matilde L. Follo, Lucio Cocco, Stefano Ratti, Alberto M. Martelli, Giuseppe Montalto, Maria Rita Emma, Melchiorre Cervello, Dariusz Rakus, Agnieszka Gizak, James A. McCubrey
Publikováno v:
Cells, Vol 11, Iss 5, p 794 (2022)
The TP53 tumor suppressor is mutated in ~75% of pancreatic cancers. The mutant TP53 protein in pancreatic ductal adenocarcinomas (PDAC) promotes tumor growth and metastasis. Attempts have been made to develop molecules that restore at least some of t
Externí odkaz:
https://doaj.org/article/b88503daf256434e9d204e634e50ec26
Autor:
Maria Rita Emma, Giuseppa Augello, Vita Di Stefano, Antonina Azzolina, Lydia Giannitrapani, Giuseppe Montalto, Melchiorre Cervello, Antonella Cusimano
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 3, p 1234 (2021)
The Mediterranean diet (MD) is a combination of foods mainly rich in antioxidants and anti-inflammatory nutrients that have been shown to have many health-enhancing effects. Extra-virgin olive oil (EVOO) is an important component of the MD. The impor
Externí odkaz:
https://doaj.org/article/3d1f27134f82441ca3224990a0b5090d
Autor:
Giuseppa Augello, Melchiorre Cervello, Lydia Giannitrapani, Maria Rita Emma, Antonina Azzolina, Antonella Cusimano, Maurizio Soresi, Giuseppe Montalto
Publikováno v:
Critical reviews in oncogenesis 26 (2021): 11–25. doi:10.1615/CritRevOncog.2020036234
info:cnr-pdr/source/autori:Antonella Cusimano; Maurizio Soresi; Giuseppe Montalto; Giuseppa Augello; Maria Rita Emma; Antonina Azzolina; Melchiorre Cervello; Lydia Giannitrapani/titolo:Hepatocellular Carcinoma: A Difficult Cancer to Treat/doi:10.1615%2FCritRevOncog.2020036234/rivista:Critical reviews in oncogenesis/anno:2021/pagina_da:11/pagina_a:25/intervallo_pagine:11–25/volume:26
info:cnr-pdr/source/autori:Antonella Cusimano; Maurizio Soresi; Giuseppe Montalto; Giuseppa Augello; Maria Rita Emma; Antonina Azzolina; Melchiorre Cervello; Lydia Giannitrapani/titolo:Hepatocellular Carcinoma: A Difficult Cancer to Treat/doi:10.1615%2FCritRevOncog.2020036234/rivista:Critical reviews in oncogenesis/anno:2021/pagina_da:11/pagina_a:25/intervallo_pagine:11–25/volume:26
Hepatocellular carcinoma (HCC) is a very peculiar cancer because it presents several molecular alterations linked to the activation of survival and antiapoptotic signal pathways that are protein in form and not easily targetable by even the newest ta
Autor:
Alessandro Gulino, Linda S. Steelman, Maria Rita Emma, Lydia Giannitrapani, Giuseppa Augello, Antonella Cusimano, James A. McCubrey, Melchiorre Cervello, Maurizio Soresi, Beatrice Belmonte, Giuseppe Montalto, Shaw M. Akula, Stephen L. Abrams
Publikováno v:
Aging (Albany NY)
Aging (Albany, N.Y. Online) (2020): 3054–3094. doi:10.18632/aging.102777
info:cnr-pdr/source/autori:Cervello M; Emma MR; Augello G; Cusimano A; Giannitrapani L; Soresi M; Akula SM; Abrams SL; Steelman LS; Gulino A; Belmonte B; Montalto G; McCubrey JA;/titolo:New landscapes and horizons in hepatocellular carcinoma therapy./doi:10.18632%2Faging.102777/rivista:Aging (Albany, N.Y. Online)/anno:2020/pagina_da:3054/pagina_a:3094/intervallo_pagine:3054–3094/volume
Aging (Albany, N.Y. Online) (2020): 3054–3094. doi:10.18632/aging.102777
info:cnr-pdr/source/autori:Cervello M; Emma MR; Augello G; Cusimano A; Giannitrapani L; Soresi M; Akula SM; Abrams SL; Steelman LS; Gulino A; Belmonte B; Montalto G; McCubrey JA;/titolo:New landscapes and horizons in hepatocellular carcinoma therapy./doi:10.18632%2Faging.102777/rivista:Aging (Albany, N.Y. Online)/anno:2020/pagina_da:3054/pagina_a:3094/intervallo_pagine:3054–3094/volume
Hepatocellular carcinoma (HCC), is the sixth most frequent form of cancer and leads to the fourth highest number of deaths each year. HCC results from a combination of environmental factors and aging as there are driver mutations at oncogenes which o
Autor:
James A. McCubrey, Lucia Condorelli, Antonella Cusimano, Roberto Puleio, Melchiorre Cervello, Antonina Azzolina, Maria Rita Emma, Lydia Giannitrapani, Giuseppa Augello, Juan L. Iovanna
Publikováno v:
Cancer letters
519 (2021): 250–262. doi:10.1016/j.canlet.2021.07.026
info:cnr-pdr/source/autori:Giuseppa Augello; Maria Rita Emma; Antonina Azzolina; Roberto Puleio; Lucia Condorelli; Antonella Cusimano; Lydia Giannitrapani; James A McCubrey; Juan Lucio Iovanna; Melchiorre Cervello/titolo:The NUPR1%2Fp73 axis contributes to sorafenib resistance in hepatocellular carcinoma/doi:10.1016%2Fj.canlet.2021.07.026/rivista:Cancer letters (Print)/anno:2021/pagina_da:250/pagina_a:262/intervallo_pagine:250–262/volume:519
519 (2021): 250–262. doi:10.1016/j.canlet.2021.07.026
info:cnr-pdr/source/autori:Giuseppa Augello; Maria Rita Emma; Antonina Azzolina; Roberto Puleio; Lucia Condorelli; Antonella Cusimano; Lydia Giannitrapani; James A McCubrey; Juan Lucio Iovanna; Melchiorre Cervello/titolo:The NUPR1%2Fp73 axis contributes to sorafenib resistance in hepatocellular carcinoma/doi:10.1016%2Fj.canlet.2021.07.026/rivista:Cancer letters (Print)/anno:2021/pagina_da:250/pagina_a:262/intervallo_pagine:250–262/volume:519
The multikinase inhibitor sorafenib was the first drug approved by the FDA for treating patients with advanced hepatocellular carcinoma (HCC). However, sorafenib resistance remains a major challenge for improving the effectiveness of HCC treatment. P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ecafc9fadd1da8c59a1c1e4606d82c3
http://hdl.handle.net/10447/518876
http://hdl.handle.net/10447/518876
Autor:
Sarah Mongiovì, Roberto Gramignoli, Giuseppa Augello, Roberto Puleio, Melchiorre Cervello, Maria Rita Emma, James A. McCubrey, Giuseppe Montalto, Antonina Azzolina, Beatrice Belmonte, Stephen C. Strom, Alessandro Gulino, Antonella Cusimano, Giovanni Cassata
Publikováno v:
International Journal of Cancer. 144:2613-2624
Hepatocellular carcinoma (HCC) is a highly malignant tumor that responds very poorly to existing therapies, most probably due to its extraordinary inter- and intra-tumor molecular heterogeneity. The modest therapeutic response to molecular targeted a
Autor:
Maria Rita Emma, Antonella Cusimano, Karen Blyth, Maurizio Soresi, Melchiorre Cervello, Angela Listi, Daniela Cabibi, Christopher L. Pin, Sergiu Coslet, Rossana Porcasi, Gianni Pantuso, Marion Rubis, Giuseppa Augello, Juan L. Iovanna, Maria Teresa Borrello, Lydia Giannitrapani, Giuseppe Montalto
Publikováno v:
Paediatrics Publications
The FASEB journal (Online) 35 (2021): e21395. doi:10.1096/fj.202002413RR
info:cnr-pdr/source/autori:Teresa Borrello M; Rita Emma M; Listi A; Rubis M; Coslet S; Augello G; Cusimano A; Cabibi D; Porcasi R; Giannitrapani L; Soresi M; Pantuso G; Blyth K; Montalto G; Pin C; Cervello M; Iovanna J;/titolo:NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response/doi:10.1096%2Ffj.202002413RR/rivista:The FASEB journal (Online)/anno:2021/pagina_da:e21395/pagina_a:/intervallo_pagine:e21395/volume:35
The FASEB journal (Online) 35 (2021): e21395. doi:10.1096/fj.202002413RR
info:cnr-pdr/source/autori:Teresa Borrello M; Rita Emma M; Listi A; Rubis M; Coslet S; Augello G; Cusimano A; Cabibi D; Porcasi R; Giannitrapani L; Soresi M; Pantuso G; Blyth K; Montalto G; Pin C; Cervello M; Iovanna J;/titolo:NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response/doi:10.1096%2Ffj.202002413RR/rivista:The FASEB journal (Online)/anno:2021/pagina_da:e21395/pagina_a:/intervallo_pagine:e21395/volume:35
Background and AimsNon-alcoholic fatty liver disease and related hepatic syndromes affect up to one third of the adult population. The molecular mechanisms underlying NAFL etiology remain elusive. Nuclear Protein 1 (NUPR1) expression increases upon c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cd733e9719455f742cc0ef85de4759e
https://ir.lib.uwo.ca/paedpub/570
https://ir.lib.uwo.ca/paedpub/570
Autor:
Noemi Lo Re, Giuseppe Montalto, Gianni Pantuso, Adele Rosalia Capitano, Maria Rita Emma, Lydia Giannitrapani, Giuseppa Augello, Maurizio Soresi, Melchiorre Cervello, Rosaria Vincenza Giglio, Rossana Porcasi, Daniela Cabibi
Publikováno v:
Biochimica and biophysica acta. Molecular and cell biology of lipids 1865 (2020). doi:10.1016/j.bbalip.2020.158792
info:cnr-pdr/source/autori:Maria R Emma; Lydia Giannitrapani; Daniela Cabibi; Rossana Porcasi; Gianni Pantuso; Giuseppa Augello; Rosaria V Giglio; Noemi Lo Re; Adele R Capitano; Giuseppe Montalto; Maurizio Soresi; Melchiorre Cervello;/titolo:Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis/doi:10.1016%2Fj.bbalip.2020.158792/rivista:Biochimica and biophysica acta. Molecular and cell biology of lipids/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume:1865
info:cnr-pdr/source/autori:Maria R Emma; Lydia Giannitrapani; Daniela Cabibi; Rossana Porcasi; Gianni Pantuso; Giuseppa Augello; Rosaria V Giglio; Noemi Lo Re; Adele R Capitano; Giuseppe Montalto; Maurizio Soresi; Melchiorre Cervello;/titolo:Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis/doi:10.1016%2Fj.bbalip.2020.158792/rivista:Biochimica and biophysica acta. Molecular and cell biology of lipids/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume:1865
Non-alcoholic fatty liver disease (NAFLD) is becoming the main cause of liver disease in Western countries, especially in morbidly obese patients (MOPs). The proprotein convertase subtilisin/kexin type 9 (PCSK9) has been recently studied because of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::066ff0385cb57a9cb33f5994d058018c
http://www.cnr.it/prodotto/i/433909
http://www.cnr.it/prodotto/i/433909
Autor:
Marion Peyrou, Maurizio Soresi, Jan Frohlich, Tommaso Mazza, Maria Rita Emma, Anna Alisi, Francesca Bonomini, Melchiorre Cervello, Manlio Vinciguerra, Daniela Cabibi, Michelangelo Foti, Kristina Kovacovicova, Cyril Sobolewski, Rita Rezzani, Francesc Villarroya, Jude A. Oben
Publikováno v:
Aging, Vol. 12, No 20 (2020) pp. 20024-20046
Aging (Albany NY)
Aging-Us
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Aging (Albany, N.Y. Online) 12 (2020): 20024–20039. doi:10.18632/aging.104182
info:cnr-pdr/source/autori:Frohlich J; Kovacovicova K; Mazza T; Emma MR; Cabibi D; Foti M; Sobolewski C; Oben JA; Peyrou M; Villarroya F; Soresi M; Rezzani R; Cervello M; Bonomini F; Alisi A; Vinciguerra M;/titolo:GDF11 induces mild hepatic fibrosis independent of metabolic health/doi:10.18632%2Faging.104182/rivista:Aging (Albany, N.Y. Online)/anno:2020/pagina_da:20024/pagina_a:20039/intervallo_pagine:20024–20039/volume:12
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Aging (Albany NY)
Aging-Us
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Aging (Albany, N.Y. Online) 12 (2020): 20024–20039. doi:10.18632/aging.104182
info:cnr-pdr/source/autori:Frohlich J; Kovacovicova K; Mazza T; Emma MR; Cabibi D; Foti M; Sobolewski C; Oben JA; Peyrou M; Villarroya F; Soresi M; Rezzani R; Cervello M; Bonomini F; Alisi A; Vinciguerra M;/titolo:GDF11 induces mild hepatic fibrosis independent of metabolic health/doi:10.18632%2Faging.104182/rivista:Aging (Albany, N.Y. Online)/anno:2020/pagina_da:20024/pagina_a:20039/intervallo_pagine:20024–20039/volume:12
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
BACKGROUND & AIMS: Growth Differentiation Factor 11 (GDF11) is an anti-aging factor, yet its role in liver diseases is not established. We evaluated the role of GDF11 in healthy conditions and in the transition from non-alcoholic fatty liver disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6011056e0ab7ef2cf4cbca8e3b937a4
http://hdl.handle.net/10447/447208
http://hdl.handle.net/10447/447208
Autor:
Antonella Cusimano, Antonina Azzolina, Giuseppe Montalto, Maria Rita Emma, Caterina Di Sano, Giuseppa Augello, Roberto Gramignoli, Melchiorre Cervello, Daniele Balasus, James A. McCubrey, Stephen C. Strom
Publikováno v:
International Journal of Oncology. 51:533-544
The beneficial health properties of the Mediterranean diet are well recognized. The principle source of fat in Mediterranean diet is extra-virgin olive oil (EVOO). Oleocanthal (OC) is a naturally occurring minor phenolic compound isolated from EVOO,